iShares Paris-Aligned ClmMSCIWldExUSAETF PABD

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis PABD

Will PABD outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin iShares Paris-Aligned ClmMSCIWldExUSAETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PABD

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 13.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

2.06 1.1 Mil
Healthcare

ASML Holding NV

1.99 1.1 Mil
Technology

Schneider Electric SE

1.37 735,912
Industrials

Novartis AG Registered Shares

1.31 706,151
Healthcare

SAP SE

1.28 690,765
Technology

AstraZeneca PLC

1.27 683,763
Healthcare

Roche Holding AG

1.23 659,434
Healthcare

ABB Ltd

1.13 605,207
Industrials

Royal Bank of Canada

1.12 602,400
Financial Services

Lvmh Moet Hennessy Louis Vuitton SE

1.10 590,117
Consumer Cyclical

Sponsor Center